Ph gains 52‑week high after FY26 earnings, raising FY27 outlook – strong Q4 profits, motion‑control & aerospace growth fuel a bullish future for investors.
Explore how Parker‑Hannifin’s new GF Piping partnership, bioreactor growth potential and Southeast Asian infrastructure wins position the company for modular fluid‑control innovation in 2026‑2031 markets.
Raymond James cuts Parker‑Hannifin’s target price, citing a 32.7x P/E above the industrial average, yet its diversified aerospace and motion‑control strengths keep long‑term investors intrigued.